AFIB - Acutus' AcQMap system/catheter for irregular heartbeat gets approval in Japan

• Acutus Medical ( NASDAQ: AFIB ) said its AcQMap High Resolution Imaging and Mapping System and AcQMap 3D Imaging and Mapping Catheter was approved in Japan.
• Acutus and its International Alliance partner Biotronik have begun training and early market development activities in preparation for significant activities in 2023, the company said in a July 27 press release.
• The company said the ultrasound-based imaging and non-contact mapping catheter are capable of capturing cardiac imaging information and cardiac activation mapping, all without touching the heart. The AcQMap System can map the electrical conduction of each heartbeat to characterize complex arrhythmias — an irregular heartbeat.
• "This approval uniquely enables electrophysiologists in Japan to employ a fully non-contact system to aid in the personalized diagnosis and treatment of patients suffering from cardiac arrhythmias," said Acutus President & CEO David Roman.
• AFIB +3.79% to $1.37 premarket July 27

For further details see: